GSK plc GSK
NYSE GSK
$47.83 -0.75 (-1.54%)
At close: Nov 19, 2026 · 4:00 PM EST

Gsk (GSK) Asset Writedowns and Impairment (2015 - 2016)

Updated

Gsk (GSK) recorded Asset Writedowns and Impairment of $36.05 million in the quarter ended Dec 31, 2016, down 88.5% from $312.6 million a year earlier.

Analysis

Gsk (GSK) Asset Writedowns and Impairment (2015 - 2016) Analysis & Trends

On a TTM basis, Gsk's Asset Writedowns and Impairment came in at $4.01 billion as of Dec 31, 2016.

  • Quarterly Asset Writedowns and Impairment has ranged from -$11.83 million in the quarter ended Sep 30, 2016 to $2.83 billion in the quarter ended Jun 30, 2016 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$11.83 million (quarter ended Sep 30, 2016), $2.83 billion (quarter ended Jun 30, 2016) and $1.15 billion (quarter ended Mar 31, 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn
9 Gsk 193.54 Bn 176.38 Bn -
10 Pfizer 156.44 Bn 103.79 Bn 12.56 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 36.05 Mn
Sep 30, 2016 -11.83 Mn
Jun 30, 2016 2.83 Bn
Mar 31, 2016 1.15 Bn
Dec 31, 2015 312.60 Mn
API Access

Gsk Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=GSK&period=max&api_key=YOUR_API_KEY